• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

六个发展中国家的国家宫颈癌政策与世界卫生组织建议的比较:叙述性综述

A Comparison of the National Cervical Cancer Policies in Six Developing Countries with the World Health Organization Recommendations: A Narrative Review.

作者信息

Amir Siti Maisara, Idris Idayu Badilla, Said Zakiah Mohd, Yusoff Hanizah Mohd, Manaf Mohd Rizal Abdul

机构信息

Department of Public Health Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia.

Ministry of Health Malaysia, Kompleks E, Pusat Pentadbiran Kerajaan Persekutuan, 62590 Putrajaya, Wilayah Persekutuan Putrajaya, Malaysia.

出版信息

Iran J Public Health. 2023 Jun;52(6):1108-1120. doi: 10.18502/ijph.v52i6.12952.

DOI:10.18502/ijph.v52i6.12952
PMID:37484154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10362820/
Abstract

BACKGROUND

This study reviewed cervical cancer policies implemented in developing countries that adhered to WHO standards. Despite long being known as a preventable disease, cervical cancer is still one of the leading causes of mortality among women. Nine out of ten cervical cancer deaths occurred in less-developed countries, suggesting that the preventive and control approaches in these countries might differ from those in developed nations.

METHODS

Cervical cancer policies in six developing countries from each WHO region were selected while related data from the Cervical Cancer Country Profiles 2021 by WHO were retrieved for comparison.

RESULTS

The cervical cancer policies that were included in this review were from Malaysia, Thailand, Iran, Kenya, Argentina, and Ukraine. According to the latest guidelines on the management of cervical cancers, WHO recommendations have been elaborated on primary, secondary, and tertiary prevention. A comparison of policies among these selected countries showed variation in each level of prevention. The cancer burden in each country was also found to determine the progression of cervical cancer prevention and policy controls in these countries.

CONCLUSION

This review emphasizes the dissimilarities of cervical cancer policies in six developing countries compared to recommendations by the WHO. Identifying these discrepancies could help policymakers in developing nations to recognize the pressing issues surrounding cervical cancer prevention and establish more effective prevention and control approaches.

摘要

背景

本研究回顾了发展中国家实施的符合世界卫生组织标准的宫颈癌政策。尽管宫颈癌长期以来一直被认为是一种可预防的疾病,但它仍是女性死亡的主要原因之一。十分之九的宫颈癌死亡病例发生在欠发达国家,这表明这些国家的预防和控制方法可能与发达国家不同。

方法

从世界卫生组织各区域选取六个发展中国家的宫颈癌政策,并检索世界卫生组织《2021年宫颈癌国家概况》中的相关数据进行比较。

结果

本综述纳入的宫颈癌政策来自马来西亚、泰国、伊朗、肯尼亚、阿根廷和乌克兰。根据宫颈癌管理的最新指南,世界卫生组织对一级、二级和三级预防提出了建议。对这些选定国家的政策进行比较发现,每个预防层面都存在差异。还发现每个国家的癌症负担决定了这些国家宫颈癌预防和政策控制的进展。

结论

本综述强调了六个发展中国家的宫颈癌政策与世界卫生组织建议的不同之处。识别这些差异有助于发展中国家的政策制定者认识到围绕宫颈癌预防的紧迫问题,并建立更有效的预防和控制方法。

相似文献

1
A Comparison of the National Cervical Cancer Policies in Six Developing Countries with the World Health Organization Recommendations: A Narrative Review.六个发展中国家的国家宫颈癌政策与世界卫生组织建议的比较:叙述性综述
Iran J Public Health. 2023 Jun;52(6):1108-1120. doi: 10.18502/ijph.v52i6.12952.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Tuberculosis结核病
4
Cervical cancer prevention in Africa: A policy analysis.非洲的宫颈癌预防:政策分析。
J Cancer Policy. 2022 Jun;32:100321. doi: 10.1016/j.jcpo.2021.100321. Epub 2022 Jan 1.
5
Case study of cervical cancer prevention in two sub-Saharan African countries: Rwanda and Sierra Leone.撒哈拉以南非洲两个国家(卢旺达和塞拉利昂)宫颈癌预防的案例研究。
Front Med (Lausanne). 2022 Sep 15;9:928685. doi: 10.3389/fmed.2022.928685. eCollection 2022.
6
Challenges faced by cervical cancer prevention programs in developing countries: a situational analysis of program organization in Argentina.发展中国家宫颈癌预防项目面临的挑战:阿根廷项目组织状况的情境分析。
Rev Panam Salud Publica. 2010 Oct;28(4):249-57. doi: 10.1590/s1020-49892010001000003.
7
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
8
National Policies to Prevent and Manage Cervical Cancer in East African Countries: A Policy Mapping Analysis.东非国家预防和管理宫颈癌的国家政策:一项政策映射分析
Cancers (Basel). 2020 Jun 10;12(6):1520. doi: 10.3390/cancers12061520.
9
Cervical cancer control in developing countries: memorandum from a WHO meeting.发展中国家的宫颈癌防治:世界卫生组织会议备忘录
Bull World Health Organ. 1996;74(4):345-51.
10
Burden of Cervical Cancer in the Eastern Mediterranean Region During the Years 2000 and 2017: Retrospective Data Analysis of the Global Burden of Disease Study.2000 年至 2017 年期间东地中海区域宫颈癌负担:全球疾病负担研究的回顾性数据分析。
JMIR Public Health Surveill. 2021 May 12;7(5):e22160. doi: 10.2196/22160.

引用本文的文献

1
Barriers and facilitators to implementing a single-visit, screen-and-treat approach with thermal ablation for cervical cancer prevention in Kenya.肯尼亚采用热消融单次就诊筛查与治疗方法预防宫颈癌的障碍与促进因素。
PLOS Glob Public Health. 2025 Sep 9;5(9):e0005166. doi: 10.1371/journal.pgph.0005166. eCollection 2025.
2
Age-period-cohort analysis of global, regional, and national cervical cancer prevalence trends in women of childbearing age (15-49 years), 1990-2021.1990 - 2021年全球、区域和国家育龄妇女(15 - 49岁)宫颈癌患病率趋势的年龄-时期-队列分析
BMC Womens Health. 2025 Jul 28;25(1):374. doi: 10.1186/s12905-025-03918-6.
3
Optimizing strategy for cervical cancer prevention in china: a comprehensive modeling analysis.中国宫颈癌预防的优化策略:一项综合模型分析
Cost Eff Resour Alloc. 2025 May 14;23(1):20. doi: 10.1186/s12962-025-00630-y.
4
Using a social marketing approach to increase the pap-smear test uptake: randomized controlled trial among women residing in urban region.采用社会营销方法提高巴氏涂片检查的接受率:对城市地区女性进行的随机对照试验
BMC Womens Health. 2025 Mar 13;25(1):114. doi: 10.1186/s12905-025-03642-1.
5
Exploring the interaction mechanisms between cervical carcinoma in situ and antibody-mediated immune responses through Mendelian randomization analysis.通过孟德尔随机化分析探索宫颈原位癌与抗体介导的免疫反应之间的相互作用机制。
Discov Oncol. 2024 Oct 17;15(1):568. doi: 10.1007/s12672-024-01456-5.

本文引用的文献

1
Incidence, Treatment and Outcomes of Cervical Cancer in Low- and Middle-income Countries.中低收入国家宫颈癌的发病情况、治疗方法和结局。
Clin Oncol (R Coll Radiol). 2021 Sep;33(9):e363-e371. doi: 10.1016/j.clon.2021.07.001. Epub 2021 Jul 15.
2
Essential Package of Palliative Care for Women With Cervical Cancer: Responding to the Suffering of a Highly Vulnerable Population.基本的宫颈癌女性舒缓护理包:回应高度脆弱人群的痛苦。
JCO Glob Oncol. 2021 Jun;7:873-885. doi: 10.1200/GO.21.00026.
3
National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects.在资源匮乏国家实施 HPV 疫苗接种计划:经验教训、挑战与未来展望。
Prev Med. 2021 Mar;144:106335. doi: 10.1016/j.ypmed.2020.106335. Epub 2021 Mar 4.
4
Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses.COVID-19 对宫颈癌筛查造成干扰后的恢复策略及其对额外诊断的影响。
Br J Cancer. 2021 Apr;124(8):1361-1365. doi: 10.1038/s41416-021-01275-3. Epub 2021 Feb 9.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
National Cervical Cancer Screening in Thailand.泰国国家宫颈癌筛查。
Asian Pac J Cancer Prev. 2021 Jan 1;22(1):25-30. doi: 10.31557/APJCP.2021.22.1.25.
7
Cervical Cancer Screening Guidelines in the Postvaccination Era: Review of the Literature.疫苗接种后时代的宫颈癌筛查指南:文献综述
J Oncol. 2020 Nov 5;2020:8887672. doi: 10.1155/2020/8887672. eCollection 2020.
8
HPV post-infection microenvironment and cervical cancer.HPV 感染后微环境与宫颈癌。
Cancer Lett. 2021 Jan 28;497:243-254. doi: 10.1016/j.canlet.2020.10.034. Epub 2020 Oct 27.
9
HPV Vaccination and the Risk of Invasive Cervical Cancer.HPV 疫苗接种与浸润性宫颈癌风险。
N Engl J Med. 2020 Oct 1;383(14):1340-1348. doi: 10.1056/NEJMoa1917338.
10
Utilization Evaluation of Human Papilloma Virus Vaccine (GARDASIL®) in Iran; A Cross-Sectional Study.伊朗人乳头瘤病毒疫苗(佳达修®)的使用情况评估;一项横断面研究。
Iran J Pharm Res. 2020 Winter;19(1):68-76. doi: 10.22037/ijpr.2020.1100923.